Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee
PSNC Pharmacy Advice Audit: Please submit your data
Community pharmacy teams have until 10th July 2020 to capture information about the advice they give to their patients and local communities, and submit that data to PSNC via PharmOutcomes. Last week pharmacies were encouraged to undertake the PSNC Pharmacy Advice Audit to capture information about the advice they give to their patients and local communities. The...
Flu vaccination service: how can you provide it in a COVID-safe way?
The number of flu vaccinations administered by community pharmacists under the NHS Advanced service grew by 20% in 2019/20 compared to the previous year, with 1,718,147 administrations being claimed to the end of March (NHSBSA data). This excellent growth rate continues to demonstrate that the convenience and accessibility of the pharmacy service is highly valued...
Supply Disruption Alert: Phenelzine Sulphate 15mg tablets (Nardil®) – Updated
On the 3rd July 2020 the Department of Health and Social Care (DHSC) confirmed the alert has been updated to reflect that ‘there is currently no confirmed resupply date’. Issue date: 25th June 2020 Alert reference: SDA/2020/011 The Department of Health and Social Care (DHSC) and NHS England and Improvement (NHSE&I) have issued a supply...
Early guidance on the 2020/21 Seasonal Influenza Vaccination Advanced Service
This PSNC Briefing provides early guidance for community pharmacy contractors and their teams on the 2020/2021 NHS Seasonal Influenza Vaccination Advanced Service in England. Information and resources to support the service are also available at psnc.org.uk/flu and additional and updated resources will be added nearer the start of the service. We strongly recommend that contractors...
Availability of Evorel products (Theramex) – Updated
Following the recent supply problems for the Evorel range of products, Theramex have provided this update. ‘Following the acquisition of Evorel by Theramex in October 2019, we have worked tirelessly with multiple manufacturing partners to resupply the product in the UK market. Since February 2020, we have produced nearly 750,000 packs across the Evorel portfolio....
NHS Health Check: Restart Preparation Webinar
Public Health England Cardiovascular Disease (CVD) Prevention team are hosting a webinar for NHS Health Check commissioners and providers, including community pharmacy teams, to support restart planning and preparation for the NHS Health Check. This webinar will highlight the relevant existing guidance and areas for consideration when restarting the programme during the COVID-19 recovery phase....
EPS prescriptions now over 85% of total items
Electronic prescriptions sent via the Electronic Prescription Service (EPS) now make up more than 85% of all dispensed prescriptions. The COVID-19 outbreak has increased the rate of use of EPS, with the service now being utilised by more GP Access/virtual hubs, walk-in centres and out of hours settings than ever before, and uptake in urgent...
NHS Test and Trace: New guidance for contractors
PSNC has today published new guidance on NHS Test and Trace for community pharmacy contractors. Since the launch of the Government’s NHS Test and Trace programme, a number of pharmacy teams across England have been asked to self-isolate in accordance with the service. PSNC has been working with NHS England and NHS Improvement (NHSE&I) to...
NHS Test and Trace – Key points for contractors as Q&As
PSNC has been working with NHS England and NHS Improvement (NHSE&I) to clarify how the Government’s NHS Test and Trace programme applies to community pharmacy to help reduce the need for large numbers of pharmacies needing to close. This briefing provides further information on the programme, gives advice on patient and staff contacts, and outlines...
Class 2 MHRA Medicines Recall: Mepacrine Hydrochloride 100mg tablets
Class 2 MHRA medicines recall – Mepacrine Hydrochloride 100mg tablets (Batch 85641) Drug alert number: EL (20) A/27 Date issued: 02 July 2020 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Mepacrine Hydrochloride 100mg tablets (Batch 85641) BCM Specials Limited BCM Specials Limited has informed the MHRA...
PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS
Final data on ViiV's cabotegravir show impressive HIV PrEP
The long-acting, injectable therapy was 66% more effective than daily oral tablets at preventing HIV
New clinical trial platform launched to accelerate COVID-19 treatments
AGILE is a 'proof of confidence engine' designed to quickly identify the most promising compounds for treatment of COVID-19
GSK links with Medicago to develop novel COVID-19 vaccine
Phase I clinical testing scheduled to begin mid-July
EU nod for Lynparza in pancreatic cancer
The drug is the only PARP inhibitor approved in this disease
Regeneron kicks off Phase III trial of COVID-19 antibody cocktail
This follows a positive review from the Independent Data Monitoring Committee of REGN-COV2 Phase I safety results
CR UK pairs with Abcam
The partnership will develop and commercialise novel custom antibodies for cancer research
UK scientists plead with PM for charity partnership fund
A £310 million cut in UK medical research investment is predicted this year
Novartis banks EC approval for Enerzair Breezhaler
The product includes the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU
NHS launches ‘Your COVID Recovery’ service
The service will help COVID-19 survivors who are still experiencing problems with breathing, mental health or other complications.
Immune Regulation teams with DynPort on COVID-19 drug
The companies will jointly evaluate the potential of ILR201104 to treat COVID-19 related Acute Respiratory Distress Syndrome (ARDS)
King's researchers win £1m grant for COVID-19 research
The grant, from the Huo Family Foundation, will support research into better understanding the immune response to SARS-CoV-2 infection
UK study to research long-term health impact of COVID-19
The PHOSP-COVID study will support the development of new strategies for clinical and rehabilitation care
Communiqué 2020 – winners announced!
The competition's first ever virtual awards ceremony racked up over 1,400 live views
King's receives £1m grant for mental health centre
The Pears Maudsley Centre for Children and Young People will bring together the world’s leading experts in clinical care and research
Partnership gets £4.4m gov grant for better liver diagnostics
The partnership includes Perspectum, the Universities of Manchester and Birmingham, Roche Diagnostics, GE Medical Systems and Jiva.Ai
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Find out more: https://www.cphi.com/europe/